← Leaderboards
Theresa A Freeman
Thomas Jefferson University
$1,916,808
Attributed
$4,928,301
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $702.8K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,928,301 · 3
By mechanism
R01$4,696,551 · 2
R03$231,750 · 1
Top collaborators
- Paula Bourke5 shared
- Brendan Gilmore5 shared
- Noreen J Hickok5 shared
- Gregory Fridman3 shared
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Steven A Farber$12,520,520
- Noreen J Hickok$7,657,282
- Brendan Gilmore$831,520
- Emad S. Alnemri$20,242,349
- Paula Bourke$831,520
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyCellsTissuesNovel StrategiesHealingBasePlasmaEngineeringPropertyLifeProductionAntimicrobialComparison InterventionAntioxidantsAntibody Titer MeasurementClinical ProtocolsCombatCoupledAntibiotic ResistanceChemokineBacterial AntigensBoneAntibiotic TherapyAnti-Bacterial Agents
Grant awards (11)
Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium$638,200
R01 · FY2025 · AR · contact PI
Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium$646,298
R01 · FY2024 · AR · contact PI
Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium$676,113
R01 · FY2022 · AR · contact PI
Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium$662,652
R01 · FY2021 · AR · contact PI
Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium$702,816
R01 · FY2020 · AR · contact PI
Non-Thermal Plasma in Biomedicine: A New Paradigm for Redox Cell Activation$336,605
R01 · FY2014 · EB · contact PI
Non-Thermal Plasma in Biomedicine: A New Paradigm for Redox Cell Activation$327,310
R01 · FY2013 · EB · contact PI
Non-Thermal Plasma in Biomedicine: A New Paradigm for Redox Cell Activation$347,168
R01 · FY2012 · EB · contact PI
Non-Thermal Plasma in Biomedicine: A New Paradigm for Redox Cell Activation$359,389
R01 · FY2011 · EB · contact PI
ROS activation of Apoptosis Signal-regulated Kinase1 (Ask1) in chondrocytes$115,875
R03 · FY2011 · DE · contact PI
ROS activation of Apoptosis Signal-regulated Kinase1 (Ask1) in chondrocytes$115,875
R03 · FY2010 · DE · contact PI